The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1640
ISSUE1640
December 27, 2021
Clascoterone Cream (Winlevi) for Acne
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Clascoterone Cream (Winlevi) for Acne
December 27, 2021 (Issue: 1640)
The FDA has approved Winlevi (Sun), a 1% cream
formulation of the androgen receptor inhibitor
clascoterone, for treatment of acne vulgaris in
patients ≥12 years old. It is the first topical androgen
receptor inhibitor to be approved by the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.